GPL Holdings, Inc. (GPLL)
OTCMKTS · Delayed Price · Currency is USD
0.0184
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
GPL Holdings Market Cap
GPL Holdings has a market cap or net worth of $4.17 million as of March 5, 2026. Its market cap has increased by 1,267.78% in one year.
Market Cap
4.17M
Enterprise Value
n/a
Revenue
376.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 19, 2007, GPL Holdings's market cap has increased from 1.76M to 4.17M, an increase of 137.51%. That is a compound annual growth rate of 4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.17M | -44.91% |
| Dec 31, 2025 | 7.58M | 5,466.65% |
| Dec 23, 2024 | 136.13K | -54.57% |
| Dec 23, 2022 | 299.69K | -2.63% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 5.90M |
| Nymox Pharmaceutical | 5.16M |
| Mosaic ImmunoEngineering | 5.10M |
| Bioxytran | 4.75M |
| Enzon Pharmaceuticals | 4.46M |
| AXIM Biotechnologies | 3.80M |
| Burzynski Research Institute | 3.42M |
| Galera Therapeutics | 3.40M |